Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion type Assertion NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_head.
- NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion description "[There is clear evidence of a tissue-based renin-angiotensin system in the prostate and studies to date suggest that AT(1)-receptor blocking drugs inhibit the growth of some prostate cancer cell lines and delay the development of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_provenance.
- NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion evidence source_evidence_literature NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_provenance.
- NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion SIO_000772 18288685 NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_provenance.
- NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion wasDerivedFrom befree-20140225 NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_provenance.
- NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_assertion wasGeneratedBy ECO_0000203 NP811118.RAU4F_Om7HoHLvVX1cN3mbiahE4MRCKQFgN-vrKpRjpEg130_provenance.